Back to results
CompletedPhase 1

Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor Occupancy

NCT00499200

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Uppsala, Sweden

View on ClinicalTrials.gov
Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor Occupancy — TrialFind